Abbott Laboratories (ABT) operating KPIs
ABTNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Jul 28, 2026Score 14/3036% above fair value
$106.20+1.63 (+1.56%)
Close on Oct 30, 2026Market cap $183.77BP/E 34.1Yield 2.26%
Abbott Laboratories scope 1+2 GHG Emissions — Established Pharmaceuticals Division (ktCO2e)
Abbott Global Sustainability Reports (2022–2024)
Latest, FY2024
133
Period ended Dec 31, 2024
Change on a year earlier
0.0%
133 in FY2023
History
7 years
Since FY2018
Sources
2
Documents cited below
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Scope 1+2 GHG Emissions — Established Pharmaceuticals Division (ktCO2e) | Year on year | Source |
|---|---|---|---|---|
| FY2024 | Dec 31, 2024 | 133 | 0.0% | Abbott 2024 Global Sustainability Report ↗ |
| FY2023 | Dec 31, 2023 | 133 | +3.1% | Abbott 2024 Global Sustainability Report ↗ |
| FY2022 | Dec 31, 2022 | 129 | -3.7% | Abbott 2024 Global Sustainability Report ↗ |
| FY2021 | Dec 31, 2021 | 134 | 0.0% | Abbott 2022 Global Sustainability Report ↗ |
| FY2020 | Dec 31, 2020 | 134 | -4.3% | Abbott 2022 Global Sustainability Report ↗ |
| FY2019 | Dec 31, 2019 | 140 | -1.4% | Abbott 2022 Global Sustainability Report ↗ |
| FY2018 | Dec 31, 2018 | 142 | – | Abbott 2022 Global Sustainability Report ↗ |
Cite this data
StockData. (2026). Abbott Laboratories Scope 1+2 GHG Emissions — Established Pharmaceuticals Division (ktCO2e), annual FY2018–FY2024 [Data set]. Compiled from Abbott Laboratories SEC filings and investor materials. https://stockdatahq.com/stocks/abt/kpis/esg-ghg-div-epd
See every metric in the Abbott Laboratories KPI table. Data updated Oct 29, 2026.